您的购物车当前为空
VLX600 是一种铁螯合氧化磷酸化抑制剂,是一种细胞渗透性抗癌剂。它通过减少肿瘤细胞中的线粒体氧化磷酸化起作用。


为众多的药物研发团队赋能,
让新药发现更简单!
VLX600 是一种铁螯合氧化磷酸化抑制剂,是一种细胞渗透性抗癌剂。它通过减少肿瘤细胞中的线粒体氧化磷酸化起作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 196 | 现货 | |
| 5 mg | ¥ 455 | 现货 | |
| 10 mg | ¥ 747 | 现货 | |
| 25 mg | ¥ 1,580 | 现货 | |
| 50 mg | ¥ 2,660 | 现货 | |
| 100 mg | ¥ 4,000 | 现货 |
| 产品描述 | VLX600 is an iron-chelating oxidative phosphorylation (OXPHOS) inhibitor, is a cell-permeable anticancer agent. It acts by reducing mitochondrial oxidative phosphorylation in tumor cells. |
| 体外活性 | VLX600 as a drug that is preferentially active against quiescent cells in colon cancer 3-D microtissues.?The anticancer activity is associated with reduced mitochondrial respiration, leading to bioenergetic catastrophe and tumour cell death.?VLX600 shows enhanced cytotoxic activity under conditions of nutrient starvation.?Importantly, VLX600 displays tumour growth inhibition in vivo. |
| 细胞实验 | HCT116, HT29, SW620, HT8, DLD and RKO cells.Concentration,0.1, 1, 10, 100μM. 72 hours |
| 分子量 | 317.35 |
| 分子式 | C17H15N7 |
| CAS No. | 327031-55-0 |
| Smiles | CC(=NNc1nnc2c(n1)[nH]c1c(C)cccc21)c1ccccn1 |
| 密度 | 1.42 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 8 mg/mL (25.21 mM), Sonication is recommended. | |||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+90% Corn Oil: 0.5 mg/mL (1.58 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多